ACB vs. CRON, THCX, GUD, CPH, WEED, FIRE, OGI, EPI, ICC, and RIV
Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), Knight Therapeutics (GUD), Cipher Pharmaceuticals (CPH), Canopy Growth (WEED), Supreme Cannabis (FIRE), Organigram (OGI), ESSA Pharma (EPI), ICC Labs (ICC), and RIV Capital (RIV). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aurora Cannabis vs.
Aurora Cannabis (TSE:ACB) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
Aurora Cannabis has a net margin of -11.53% compared to Cronos Group's net margin of -56.43%. Cronos Group's return on equity of -5.29% beat Aurora Cannabis' return on equity.
Aurora Cannabis received 461 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 63.10% of users gave Aurora Cannabis an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.
Aurora Cannabis presently has a consensus price target of C$5.85, indicating a potential upside of 5.22%. Cronos Group has a consensus price target of C$3.18, indicating a potential upside of 10.80%. Given Cronos Group's higher probable upside, analysts clearly believe Cronos Group is more favorable than Aurora Cannabis.
13.4% of Aurora Cannabis shares are held by institutional investors. Comparatively, 16.0% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Aurora Cannabis has a beta of 2.71, indicating that its stock price is 171% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.
Aurora Cannabis has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.
Summary
Aurora Cannabis beats Cronos Group on 11 of the 17 factors compared between the two stocks.
Get Aurora Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aurora Cannabis Competitors List
Related Companies and Tools
This page (TSE:ACB) was last updated on 1/19/2025 by MarketBeat.com Staff
Free ACB Stock Alerts